Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Biochemical and Biophysical Research Communications|February 22, 2001
Platelet-associated tissue factor contributes to the collagen-triggered activation of blood coagulationA Zillmann, T Luther, I Müller, et al.Biomedica Biochimica Acta|January 1, 1991
Production and characterization of monoclonal antibodies against carcinoembryonic antigen (CEA)P Jantscheff, V Böttger, M Price, et al.Biological Chemistry|April 2, 1998
Immunological and functional analyses of the extracellular domain of human tissue factorV Magdolen, S Albrecht, M Kotzsch, et al.Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1997
Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitusM Zumbach, M Hofmann, V Borcea, et al.British Journal of Cancer|January 7, 2010
Co-detection of members of the urokinase plasminogen activator system in tumour tissue and serum correlates with a poor prognosis for soft-tissue sarcoma patientsH Taubert, P Würl, T Greither, et al.Thrombosis Research|March 9, 2000
Epitope mapping of monoclonal antibodies directed to PAI-1 using PAI-1/PAI-2 chimera and PAI-1-derived synthetic peptidesB Muehlenweg, E Guthaus, N A de Prada, et al.International Journal of Oncology|September 21, 2000
New ELISA for quantitation of human urokinase receptor (CD87) in cancerM Kotzsch, T Luther, N Harbeck, et al.Anticancer Research|March 2, 2005
Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancerB Werle, M Kotzsch, T T Lah, et al.International Journal of Oncology|May 10, 2007
Are overexpressed alternative survivin transcripts in human bladder cancer suitable targets for siRNA-mediated in vitro inhibition?D Wuttig, D Kunze, S Fuessel, et al.Pageof 3